tiprankstipranks
Trending News
More News >
Claritas Pharmaceuticals (CLAZF)
OTHER OTC:CLAZF
US Market

Claritas Pharmaceuticals (CLAZF) Income Statement

Compare
25 Followers

Claritas Pharmaceuticals Income Statement

Last quarter (Q3 2023), Claritas Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Claritas Pharmaceuticals's net income was $0.00. See Claritas Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 0.00$ 0.00$ -184.00K$ 9.45M$ 11.10M
Depreciation and Amortization
$ 228.49K$ 236.56K$ -184.00K$ 9.45M$ 11.10M
EBITDA
$ 0.00$ 0.00$ -2.79M$ -9.50M$ 18.14M
Operating Income
$ 0.00$ 0.00$ -3.28M$ -25.88M$ -4.59M
Other Income/Expenses
$ 0.00$ 0.00$ -858.00K$ -16.38M$ 17.94M
Pretax Income
$ 0.00$ 0.00$ -674.00K$ -25.83M$ 6.84M
Net Income
$ 0.00$ 0.00$ 4.21M$ -21.21M$ 6.93M
Per Share Metrics
Basic EPS
$ 0.00$ 0.00$ 0.17$ -0.95$ 0.64
Diluted EPS
$ 0.00$ 0.00$ 0.17$ -0.95$ 0.64
Weighted Average Shares Outstanding
0.00 0.00 26.69M 22.44M 10.92M
Weighted Average Shares Outstanding (Diluted)
0.00 0.00 26.69M 22.44M 10.92M
Currency in USD

Claritas Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis